34 related articles for article (PubMed ID: 7749214)
1. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
[TBL] [Abstract][Full Text] [Related]
2. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
3. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.
Dereuddre S; Delaporte C; Jacquemin-Sablon A
Cancer Res; 1997 Oct; 57(19):4301-8. PubMed ID: 9331091
[TBL] [Abstract][Full Text] [Related]
4. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Lelièvre S; Benchokroun Y; Larsen AK
Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
[TBL] [Abstract][Full Text] [Related]
5. Multiple resistance mechanisms in Chinese hamster cells resistant to 9-hydroxyellipticine.
Larsen AK; Jacquemin-Sablon A
Cancer Res; 1989 Dec; 49(24 Pt 1):7115-9. PubMed ID: 2582453
[TBL] [Abstract][Full Text] [Related]
6. [Cellular resistance to DNA-topoisomerase II inhibitors].
Jacquemin-Sablon A; Bojanowski K; Casabianca-Pignède MR; Crémier S; Delaporte C; Khelifa T; Markovits J; René B; Saucier JM; Larsen AK
Bull Cancer; 1994 May; 81(5):381-5. PubMed ID: 7749214
[TBL] [Abstract][Full Text] [Related]
7. [Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus].
René B; Fossé P; Khélifa T; Jacquemin-Sablon A; Bailly C
Bull Cancer; 1997 Oct; 84(10):941-8. PubMed ID: 9435795
[TBL] [Abstract][Full Text] [Related]
8. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
9. [Multiple drug resistance of tumor cells: manifestations, genetic basis, clinical aspects].
Gudkov AV
Mol Gen Mikrobiol Virusol; 1987 Aug; (8):3-9. PubMed ID: 3317023
[TBL] [Abstract][Full Text] [Related]
10. Altered DNA topoisomerase II in multidrug resistance.
Beck WT; Danks MK; Wolverton JS; Granzen B; Chen M; Schmidt CA; Bugg BY; Friche E; Suttle DP
Cytotechnology; 1993; 11(2):115-9. PubMed ID: 7764055
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in Chinese hamster lung and mouse tumor cells.
Biedler JL; Chang TD; Meyers MB; Peterson RH; Spengler BA
Cancer Treat Rep; 1983 Oct; 67(10):859-67. PubMed ID: 6354433
[TBL] [Abstract][Full Text] [Related]
12. [Pleiotropic resistance associated with topoisomerases].
Riou JF; Pommier Y
Bull Cancer; 1994 Dec; 81 Suppl 2():62s-68s. PubMed ID: 7727861
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
